These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 3553952)

  • 1. Comparative Study of the Efficacy and Side Effects of Brand-Name and Generic Clozapine for Long-Term Maintenance Treatment Among Korean Patients With Schizophrenia: A Retrospective Naturalistic Mirror-Image Study.
    Kang N; Yoon HS; Kim SH; Jeong JH; Kim M; Kwon JS
    Psychiatry Investig; 2024 Mar; 21(3):311-320. PubMed ID: 38569589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of GA-RxODE (Genetics Algorithms and Running simulations from Ordinary Differential Equations-based model) method to optimize bioequivalence studies.
    Nuske EO; Morozov M; Alejandro Serra H
    Pharmacol Res Perspect; 2021 Oct; 9(5):e00824. PubMed ID: 34609078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brand-Name Antidepressants Outperform Their Generic Counterparts in Preventing Hospitalization for Depression: The Real-World Evidence from Taiwan.
    Hsu CW; Lee SY; Yang YH; Wang LJ
    Int J Neuropsychopharmacol; 2020 Dec; 23(10):653-661. PubMed ID: 32598470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplant coordinators' perceived impact of availability of multiple generic immunosuppression therapies on patients, workload, and posttransplant maintenance therapy.
    Parker K; Zagadailov EA; Bruno AS; Wiland AM
    J Transplant; 2013; 2013():897434. PubMed ID: 23365717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model.
    Zuluaga AF; Agudelo M; Cardeño JJ; Rodriguez CA; Vesga O
    PLoS One; 2010 May; 5(5):e10744. PubMed ID: 20505762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.
    Kesselheim AS; Stedman MR; Bubrick EJ; Gagne JJ; Misono AS; Lee JL; Brookhart MA; Avorn J; Shrank WH
    Drugs; 2010 Mar; 70(5):605-21. PubMed ID: 20329806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.
    Kesselheim AS; Misono AS; Lee JL; Stedman MR; Brookhart MA; Choudhry NK; Shrank WH
    JAMA; 2008 Dec; 300(21):2514-26. PubMed ID: 19050195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.
    Bourgault C; Elstein E; Le Lorier J; Suissa S
    CMAJ; 1999 Aug; 161(3):255-60. PubMed ID: 10463046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinequivalence and drug toxicity. How great is the problem and what can be done?
    Gleiter CH; Gundert-Remy U
    Drug Saf; 1994 Jul; 11(1):1-6. PubMed ID: 7917077
    [No Abstract]   [Full Text] [Related]  

  • 10. Generic drugs revisited.
    Med Lett Drugs Ther; 2009 Oct; 51(1323):81-2. PubMed ID: 19838144
    [No Abstract]   [Full Text] [Related]  

  • 11. Generic substitution: the use of medicinal products containing different salts and implications for safety and efficacy.
    Verbeeck RK; Kanfer I; Walker RB
    Eur J Pharm Sci; 2006 May; 28(1-2):1-6. PubMed ID: 16413762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generic drug substitution revisited.
    Strom BL
    N Engl J Med; 1987 Jun; 316(23):1456-62. PubMed ID: 3553952
    [No Abstract]   [Full Text] [Related]  

  • 13. Substituting generic drugs: state roles.
    Cauchi R
    NCSL Legisbrief; 2009; 17(25):1-2. PubMed ID: 19526654
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefits and liabilities of generic prescribing.
    Lee AM
    W V Med J; 1972 Jun; 68(6):161-6. PubMed ID: 4504384
    [No Abstract]   [Full Text] [Related]  

  • 15. Generic vs. brand name drugs--defining and enforcing standards.
    Lasagna LC
    Internist; 1979 May; 20(4):11, 13. PubMed ID: 10316827
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.